Comparison of Cardiac Index (CI) Measurements Performed With Different Methods
1 other identifier
observational
50
0 countries
N/A
Brief Summary
The aim of the study is to determine the correlation of the results of cardiac index (CI) measurements performed with use of bioreactance technology with the results of measurements made with the use of transpulmonary thermodilution. Both methods will be evaluated in reference to measurements based on echocardiography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2022
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 31, 2022
CompletedStudy Start
First participant enrolled
February 1, 2022
CompletedFirst Posted
Study publicly available on registry
February 11, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedFebruary 11, 2022
February 1, 2022
1.8 years
January 31, 2022
February 10, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Cardiac Index value measured by the transpulmonary thermodilution technique
The cardiac index is expressed with units : Liters/minute/meter2
The results of three measurements will be documented within five minutes
Cardiac Index value measured with use of bioreactance technology
The cardiac index is expressed with units : Liters/minute/meter2
The results of ten measurements at intervals of 30 seconds will be documented within five minutes
Cardiac index value determined with use an ultrasound technique (echocardiography)
The cardiac index is expressed with units : Liters/minute/meter2
The results of three measurements will be documented within five minutes
Eligibility Criteria
50 critically ill adult patients (requiring haemodynamic monitoring and mechanical ventilation) treated in the ICU for intracranial pathology
You may qualify if:
- critically ill adult patients (requiring haemodynamic monitoring and mechanical ventilation) treated in the ICU for a intracranial pathology
You may not qualify if:
- Age under 18
- Presence of pleural effusion or pericardium (confirmed by chest X-ray and / or ultrasound / echocardiography)
- Presence of aortic / mitral valve pathology
- Presence of an implanted pacemaker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (10)
Geerts BF, Aarts LP, Jansen JR. Methods in pharmacology: measurement of cardiac output. Br J Clin Pharmacol. 2011 Mar;71(3):316-30. doi: 10.1111/j.1365-2125.2010.03798.x.
PMID: 21284692BACKGROUNDDemiselle J, Mercat A, Asfar P. Is there still a place for the Swan-Ganz catheter? Yes. Intensive Care Med. 2018 Jun;44(6):954-956. doi: 10.1007/s00134-018-5158-0. Epub 2018 May 23. No abstract available.
PMID: 29796915BACKGROUNDKobe J, Mishra N, Arya VK, Al-Moustadi W, Nates W, Kumar B. Cardiac output monitoring: Technology and choice. Ann Card Anaesth. 2019 Jan-Mar;22(1):6-17. doi: 10.4103/aca.ACA_41_18.
PMID: 30648673BACKGROUNDKeren H, Burkhoff D, Squara P. Evaluation of a noninvasive continuous cardiac output monitoring system based on thoracic bioreactance. Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H583-9. doi: 10.1152/ajpheart.00195.2007. Epub 2007 Mar 23.
PMID: 17384132BACKGROUNDSquara P, Denjean D, Estagnasie P, Brusset A, Dib JC, Dubois C. Noninvasive cardiac output monitoring (NICOM): a clinical validation. Intensive Care Med. 2007 Jul;33(7):1191-1194. doi: 10.1007/s00134-007-0640-0. Epub 2007 Apr 26.
PMID: 17458538BACKGROUNDRaval NY, Squara P, Cleman M, Yalamanchili K, Winklmaier M, Burkhoff D. Multicenter evaluation of noninvasive cardiac output measurement by bioreactance technique. J Clin Monit Comput. 2008 Apr;22(2):113-9. doi: 10.1007/s10877-008-9112-5. Epub 2008 Mar 14.
PMID: 18340540BACKGROUNDPorter TR, Shillcutt SK, Adams MS, Desjardins G, Glas KE, Olson JJ, Troughton RW. Guidelines for the use of echocardiography as a monitor for therapeutic intervention in adults: a report from the American Society of Echocardiography. J Am Soc Echocardiogr. 2015 Jan;28(1):40-56. doi: 10.1016/j.echo.2014.09.009. No abstract available.
PMID: 25559474BACKGROUNDMalik SB, Chen N, Parker RA 3rd, Hsu JY. Transthoracic Echocardiography: Pitfalls and Limitations as Delineated at Cardiac CT and MR Imaging. Radiographics. 2017 Mar-Apr;37(2):383-406. doi: 10.1148/rg.2017160105. Epub 2017 Feb 17.
PMID: 28212053BACKGROUNDLing HZ, Gallardo-Arozena M, Company-Calabuig AM, Nicolaides KH, Kametas NA. Clinical validation of bioreactance for the measurement of cardiac output in pregnancy. Anaesthesia. 2020 Oct;75(10):1307-1313. doi: 10.1111/anae.15110. Epub 2020 May 29.
PMID: 32469423BACKGROUNDLamia B, Kim HK, Severyn DA, Pinsky MR. Cross-comparisons of trending accuracies of continuous cardiac-output measurements: pulse contour analysis, bioreactance, and pulmonary-artery catheter. J Clin Monit Comput. 2018 Feb;32(1):33-43. doi: 10.1007/s10877-017-9983-4. Epub 2017 Feb 10.
PMID: 28188408BACKGROUND
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 31, 2022
First Posted
February 11, 2022
Study Start
February 1, 2022
Primary Completion
December 1, 2023
Study Completion
December 1, 2023
Last Updated
February 11, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share
There is not a plan to make IPD available